NCT07793942
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07793942
Title A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)
Acronym MK-2010-002
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CHE

Facility Status City State Zip Country Details
New Jersey Cancer Care ( Site 7002) Belleville New Jersey 07109 United States Details
START Astera, LLC ( Site 0220) East Brunswick New Jersey 08816 United States Details
Taylor Cancer Research Center ( Site 9500) Maumee Ohio 43537 United States Details
Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8001) Eugene Oregon 97401 United States Details
Cantonal Hospital St.Gallen ( Site 1100) Sankt Gallen Canton of St. Gallen 9007 Switzerland Details
CHUV (centre hospitalier universitaire vaudois) ( Site 1101) Lausanne Canton of Vaud 1011 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field